These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26810628)

  • 21. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression.
    Blom MB; Spinhoven P; Hoffman T; Jonker K; Hoencamp E; Haffmans PM; van Dyck R
    J Affect Disord; 2007 Dec; 104(1-3):119-26. PubMed ID: 17467059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice.
    van der Lem R; van der Wee NJ; van Veen T; Zitman FG
    Psychother Psychosom; 2012; 81(4):226-34. PubMed ID: 22584117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An adaptationist perspective on the etiology of depression.
    Durisko Z; Mulsant BH; Andrews PW
    J Affect Disord; 2015 Feb; 172():315-23. PubMed ID: 25451432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy.
    Pinquart M; Duberstein PR; Lyness JM
    Am J Psychiatry; 2006 Sep; 163(9):1493-501. PubMed ID: 16946172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression.
    Kwan BM; Dimidjian S; Rizvi SL
    Behav Res Ther; 2010 Aug; 48(8):799-804. PubMed ID: 20462569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based recommendations for the prescription of exercise for major depressive disorder.
    Rethorst CD; Trivedi MH
    J Psychiatr Pract; 2013 May; 19(3):204-12. PubMed ID: 23653077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mistreatment of major depressive disorder.
    Paris J
    Can J Psychiatry; 2014 Mar; 59(3):148-51. PubMed ID: 24881163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmacologic treatment of pediatric major depressive disorder.
    Boylan K; Romero S; Birmaher B
    Psychopharmacology (Berl); 2007 Mar; 191(1):27-38. PubMed ID: 16896960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
    Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM
    J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practising evidence-based medicine in an era of high placebo response: number needed to treat reconsidered.
    Roose SP; Rutherford BR; Wall MM; Thase ME
    Br J Psychiatry; 2016 May; 208(5):416-20. PubMed ID: 27143006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment response in type 2 diabetes patients with major depression.
    Gois C; Dias VV; Carmo I; Duarte R; Ferro A; Santos AL; Sousa F; Barbosa A
    Clin Psychol Psychother; 2014; 21(1):39-48. PubMed ID: 22962030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supportive psychotherapy for perinatal depression: preliminary data for adherence and response.
    Freeman MP; Davis MF
    Depress Anxiety; 2010; 27(1):39-45. PubMed ID: 19691033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Residual symptoms and recurrence in major depressive disorder].
    Spadone C; Corruble E
    Encephale; 2010 Dec; 36 Suppl 5():S108-11. PubMed ID: 21211628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The generalisability of depression trials to clinical practice].
    van der Lem R; van der Wee NJ; van Veen T; Zitman FG
    Tijdschr Psychiatr; 2015; 57(8):579-87. PubMed ID: 26402894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive socioeconomic and clinical profiles of antidepressant response and remission.
    Jain FA; Hunter AM; Brooks JO; Leuchter AF
    Depress Anxiety; 2013 Jul; 30(7):624-30. PubMed ID: 23288666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resting-state connectivity predictors of response to psychotherapy in major depressive disorder.
    Crowther A; Smoski MJ; Minkel J; Moore T; Gibbs D; Petty C; Bizzell J; Schiller CE; Sideris J; Carl H; Dichter GS
    Neuropsychopharmacology; 2015 Jun; 40(7):1659-73. PubMed ID: 25578796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moving pharmacoepigenetics tools for depression toward clinical use.
    Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
    J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.